Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
www.ahrq.gov
space
MEPS Home Medical Expenditure Panel Survey
FAQ Contact MEPS Espanol Site Map
 
space
spacer
Publication Details
  Publication Details
Title:
   Choice of Angiotensin Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers among Hypertensive Adults: Nationally Representative Estimates, 1997-2004
Product type:
   Working Paper 9001
MEPS component:
   Household Component
Publication date:
   April 2, 2009
Description:
   We use nationally representative data from the 1997-2004 Medical Expenditure Panel Survey. Our sample is comprised of adults (age 35+) who reported treatment for hypertension and used a RAAS- modifier. We begin by estimating the total number of persons who purchased an ACEI or an ARB during the year for each year from 1997-2004. Then, we combine data for the years 2002-04 to estimate a multivariate logistic model to identify socioeconomic and clinical factors associated with an increased, or decreased, probability of ARB use.
Author(s):
   G. Edward Miller, PhD., Jessica Banthin, PhD. and Sedrakyan A.
Agency:
   Rockville (MD): Agency for Healthcare Research and Quality
Source:
   Web Only Publication
PDF link:
   data_files/publications/workingpapers/wp_09001.pdf (58 KB)
  Back to search results   Printing tips   Accessibility info

MEPS HOME . MEPS FAQ . CONTACT MEPS . MEPS SITE MAP . MEPS PRIVACY POLICY . ACCESSIBILITY TOOLS
""